Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Vamil Divan is an analyst at Guggenheim. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/09/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 07/09/2024 | INSM | Buy Now | Insmed | $69.40 | 36.89% | $70 → $95 | Maintains | Buy | Get Alert |
| 06/18/2024 | AVTE | Buy Now | Aerovate Therapeutics | $1.70 | — | — | Downgrade | Buy → Neutral | Get Alert |
| 05/10/2024 | RVNC | Buy Now | Revance Therapeutics | $2.87 | 179.23% | $9 → $8 | Maintains | Neutral | Get Alert |
| 04/23/2024 | ANIP | Buy Now | ANI Pharmaceuticals | $61.51 | 25.18% | → $77 | Reiterates | Buy → Buy | Get Alert |
| 04/09/2024 | ALPN | Buy Now | Alpine Immune Sciences | — | — | → $55 | Initiates | → Buy | Get Alert |
| 04/05/2024 | VERA | Buy Now | Vera Therapeutics | $35.00 | 60% | → $56 | Reiterates | Buy → Buy | Get Alert |
| 03/27/2024 | VERA | Buy Now | Vera Therapeutics | $35.00 | 60% | $27 → $56 | Maintains | Buy | Get Alert |
| 03/27/2024 | TVTX | Buy Now | Travere Therapeutics | $9.78 | — | — | Downgrade | Buy → Neutral | Get Alert |
| 03/22/2024 | ABBV | Buy Now | AbbVie | $167.75 | 13.26% | $188 → $190 | Maintains | Buy | Get Alert |
| 03/05/2024 | ANIP | Buy Now | ANI Pharmaceuticals | $61.51 | 25.18% | $70 → $77 | Maintains | Buy | Get Alert |
| 02/27/2024 | INSM | Buy Now | Insmed | $69.40 | -22.19% | $52 → $54 | Maintains | Buy | Get Alert |
| 02/23/2024 | PFE | Buy Now | Pfizer | $27.64 | 30.22% | → $36 | Initiates | → Buy | Get Alert |
| 01/29/2024 | RVNC | Buy Now | Revance Therapeutics | $2.87 | 214.14% | $16 → $9 | Downgrade | Buy → Neutral | Get Alert |
| 01/26/2024 | KRTX | Buy Now | Karuna Therapeutics | — | — | $245 → $330 | Downgrade | Buy → Neutral | Get Alert |
| 10/19/2023 | ANIP | Buy Now | ANI Pharmaceuticals | $61.51 | 17.05% | → $72 | Reiterates | Buy → Buy | Get Alert |
| 09/22/2023 | TVTX | Buy Now | Travere Therapeutics | $9.78 | 84.05% | $25 → $18 | Maintains | Buy | Get Alert |
| 09/13/2023 | ANIP | Buy Now | ANI Pharmaceuticals | $61.51 | 17.05% | → $72 | Reiterates | Buy → Buy | Get Alert |
| 09/07/2023 | SAGE | Buy Now | Sage Therapeutics | $11.39 | 75.59% | $19 → $20 | Maintains | Neutral | Get Alert |
| 09/05/2023 | INSM | Buy Now | Insmed | $69.40 | -25.07% | $50 → $52 | Reiterates | Buy → Buy | Get Alert |
| 08/18/2023 | CALT | Buy Now | Calliditas Therapeutics | $38.89 | -53.72% | $21 → $18 | Maintains | Neutral | Get Alert |
| 08/16/2023 | VERA | Buy Now | Vera Therapeutics | $35.00 | -22.86% | → $27 | Initiates | → Buy | Get Alert |
| 08/10/2023 | ANIP | Buy Now | ANI Pharmaceuticals | $61.51 | 17.05% | $62 → $72 | Maintains | Buy | Get Alert |
| 08/08/2023 | SAGE | Buy Now | Sage Therapeutics | $11.39 | 66.81% | $45 → $19 | Maintains | Neutral | Get Alert |
| 07/27/2023 | ANIP | Buy Now | ANI Pharmaceuticals | $61.51 | 0.8% | $59 → $62 | Maintains | Buy | Get Alert |
| 07/26/2023 | INSM | Buy Now | Insmed | $69.40 | -27.95% | → $50 | Initiates | → Buy | Get Alert |
| 06/15/2023 | RLMD | Buy Now | Relmada Therapeutics | $3.77 | 590.57% | → $26 | Reiterates | Buy → Buy | Get Alert |
| 06/12/2023 | KDNY | Buy Now | Chinook Therapeutics | — | — | $35 → $40 | Downgrade | Buy → Neutral | Get Alert |
| 06/07/2023 | RVNC | Buy Now | Revance Therapeutics | $2.87 | 1121.64% | $33 → $35 | Maintains | Buy | Get Alert |
| 05/09/2023 | ANIP | Buy Now | ANI Pharmaceuticals | $61.51 | -4.08% | $55 → $59 | Maintains | Buy | Get Alert |
| 05/02/2023 | KDNY | Buy Now | Chinook Therapeutics | — | — | $43 → $35 | Maintains | Buy | Get Alert |
| 05/02/2023 | TVTX | Buy Now | Travere Therapeutics | $9.78 | 135.17% | $40 → $23 | Maintains | Buy | Get Alert |
| 04/28/2023 | ABBV | Buy Now | AbbVie | $167.75 | 1.94% | $172 → $171 | Maintains | Buy | Get Alert |
| 04/03/2023 | SCYX | Buy Now | SCYNEXIS | $1.97 | 356.85% | $8 → $9 | Maintains | Buy | Get Alert |
| 03/01/2023 | SCYX | Buy Now | SCYNEXIS | $1.97 | 306.09% | → $8 | Initiates | → Buy | Get Alert |
| 03/01/2023 | CALT | Buy Now | Calliditas Therapeutics | $38.89 | -53.72% | → $18 | Initiates | → Neutral | Get Alert |
| 03/01/2023 | KDNY | Buy Now | Chinook Therapeutics | — | — | → $43 | Initiates | → Buy | Get Alert |
| 03/01/2023 | AVTE | Buy Now | Aerovate Therapeutics | $1.70 | 2022.02% | → $36 | Initiates | → Buy | Get Alert |
| 03/01/2023 | GOSS | Buy Now | Gossamer Bio | $1.16 | — | — | Initiates | → Neutral | Get Alert |
| 03/01/2023 | ANIP | Buy Now | ANI Pharmaceuticals | $61.51 | -10.58% | → $55 | Initiates | → Buy | Get Alert |
| 03/01/2023 | JNJ | Buy Now | Johnson & Johnson | $146.61 | 9.82% | → $161 | Initiates | → Neutral | Get Alert |
| 03/01/2023 | ABBV | Buy Now | AbbVie | $167.75 | 2.53% | → $172 | Initiates | → Buy | Get Alert |
| 03/01/2023 | TVTX | Buy Now | Travere Therapeutics | $9.78 | 278.32% | → $37 | Initiates | → Buy | Get Alert |
| 02/17/2023 | SAGE | Buy Now | Sage Therapeutics | $11.39 | 295.08% | $37 → $45 | Maintains | Neutral | Get Alert |
| 11/15/2022 | STSA | Buy Now | Satsuma Pharma | — | — | $13 → $2 | Downgrade | Buy → Neutral | Get Alert |
| 09/09/2022 | RVNC | Buy Now | Revance Therapeutics | $2.87 | 947.12% | $26 → $30 | Maintains | Buy | Get Alert |
| 08/10/2022 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.37 | 9.38% | $27 → $19 | Maintains | Neutral | Get Alert |
| 08/09/2022 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.37 | 9.38% | $27 → $19 | Maintains | Neutral | Get Alert |
| 08/09/2022 | KRTX | Buy Now | Karuna Therapeutics | — | — | $190 → $276 | Maintains | Buy | Get Alert |
| 08/08/2022 | NBIX | Buy Now | Neurocrine Biosciences | $142.34 | -31.15% | $95 → $98 | Maintains | Neutral | Get Alert |
| 07/28/2022 | ALKS | Buy Now | Alkermes | $24.16 | 40.73% | $36 → $34 | Maintains | Buy | Get Alert |
| 05/25/2022 | CABA | Buy Now | Cabaletta Bio | $7.68 | 30.21% | $20 → $10 | Maintains | Buy | Get Alert |
| 05/13/2022 | STSA | Buy Now | Satsuma Pharma | — | — | $15 → $13 | Maintains | Buy | Get Alert |
| 05/11/2022 | RVNC | Buy Now | Revance Therapeutics | $2.87 | 807.5% | → $26 | Maintains | Buy | Get Alert |
| 05/03/2022 | AXSM | Buy Now | Axsome Therapeutics | $81.03 | -39.53% | $51 → $49 | Maintains | Buy | Get Alert |
| 05/02/2022 | LLY | Buy Now | Eli Lilly | $933.32 | -61.86% | $315 → $356 | Maintains | Buy | Get Alert |
| 04/27/2022 | KRTX | Buy Now | Karuna Therapeutics | — | — | $178 → $190 | Maintains | Buy | Get Alert |
| 04/19/2022 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.37 | 55.44% | $28 → $27 | Maintains | Neutral | Get Alert |
| 03/18/2022 | CABA | Buy Now | Cabaletta Bio | $7.68 | 160.42% | $22 → $20 | Maintains | Buy | Get Alert |
| 03/16/2022 | XERS | Buy Now | Xeris Biopharma Holdings | $2.15 | 178.42% | $8 → $6 | Maintains | Buy | Get Alert |
| 03/03/2022 | SAGE | Buy Now | Sage Therapeutics | $11.39 | 259.96% | $44 → $41 | Maintains | Neutral | Get Alert |
| 03/03/2022 | KRTX | Buy Now | Karuna Therapeutics | — | — | $182 → $178 | Maintains | Buy | Get Alert |
| 03/03/2022 | BHVN | Buy Now | Biohaven | $35.25 | 336.88% | $144 → $154 | Maintains | Buy | Get Alert |
| 03/03/2022 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.37 | 61.2% | $33 → $28 | Maintains | Neutral | Get Alert |
| 02/04/2022 | ABBV | Buy Now | AbbVie | $167.75 | -1.04% | $154 → $166 | Maintains | Buy | Get Alert |
| 02/04/2022 | LLY | Buy Now | Eli Lilly | $933.32 | -68.61% | $302 → $293 | Maintains | Buy | Get Alert |
| 01/05/2022 | ABBV | Buy Now | AbbVie | $167.75 | -8.2% | $132 → $154 | Maintains | Buy | Get Alert |
| 12/14/2021 | PFE | Buy Now | Pfizer | $27.64 | 102.57% | — | Maintains | Neutral | Get Alert |
| 12/07/2021 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.37 | 49.68% | — | Maintains | Neutral | Get Alert |
| 11/18/2021 | BHVN | Buy Now | Biohaven Pharma Hldgs | $35.25 | 308.51% | — | Maintains | Buy | Get Alert |
| 11/18/2021 | RLMD | Buy Now | Relmada Therapeutics | $3.77 | 1228.02% | — | Initiates | → Buy | Get Alert |
| 11/01/2021 | ABBV | Buy Now | AbbVie | $167.75 | -21.31% | $131 → $132 | Maintains | Buy | Get Alert |
| 09/01/2021 | ABBV | Buy Now | AbbVie | $167.75 | -21.91% | → $131 | Reiterates | → Buy | Get Alert |
| 05/03/2021 | ABBV | Buy Now | AbbVie | $167.75 | -23.7% | $126 → $128 | Maintains | Buy | Get Alert |
| 02/04/2021 | ABBV | Buy Now | AbbVie | $167.75 | -24.89% | $117 → $126 | Maintains | Buy | Get Alert |
| 06/29/2020 | ABBV | Buy Now | AbbVie | $167.75 | -34.43% | $101 → $110 | Maintains | Buy | Get Alert |
| 05/04/2020 | ABBV | Buy Now | AbbVie | $167.75 | -39.79% | $100 → $101 | Maintains | Buy | Get Alert |
